Biomarkers to Predict and Monitor Response to Infliximab

NCT04655729 · clinicaltrials.gov ↗

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Infliximab

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]